Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S G Perez
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
Doctor-Patient Sexual Relationships in Medical Oaths
Journal of Medical Ethics
Arts
Humanities
Legal Aspects
Health Policy
Health
Ethics
Issues
Related publications
Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin
Neoplasma
Cancer Research
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning
American Journal of Hematology
Hematology
Busulfan Fludarabine vs Busulfan Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis
Bone Marrow Transplantation
Transplantation
Hematology
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
